PERSONENI, NICOLA
 Distribuzione geografica
Continente #
NA - Nord America 1.273
EU - Europa 304
AS - Asia 200
AF - Africa 17
SA - Sud America 9
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1.809
Nazione #
US - Stati Uniti d'America 1.233
CN - Cina 102
IT - Italia 94
GB - Regno Unito 47
DE - Germania 45
FR - Francia 39
CA - Canada 38
IN - India 22
KR - Corea 20
IE - Irlanda 11
JP - Giappone 11
ZA - Sudafrica 11
TW - Taiwan 10
CZ - Repubblica Ceca 9
NL - Olanda 8
TH - Thailandia 8
RO - Romania 7
SG - Singapore 7
GR - Grecia 6
HK - Hong Kong 6
RU - Federazione Russa 6
CL - Cile 5
BR - Brasile 4
IL - Israele 4
SE - Svezia 4
UA - Ucraina 4
ES - Italia 3
FI - Finlandia 3
IR - Iran 3
LT - Lituania 3
VN - Vietnam 3
AU - Australia 2
BE - Belgio 2
DZ - Algeria 2
EG - Egitto 2
EU - Europa 2
LV - Lettonia 2
MK - Macedonia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
TR - Turchia 2
TZ - Tanzania 2
AN - Antille olandesi 1
AT - Austria 1
CH - Svizzera 1
DK - Danimarca 1
HR - Croazia 1
MX - Messico 1
PL - Polonia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 1.809
Città #
Fairfield 151
Houston 147
Woodbridge 109
Seattle 99
Ashburn 83
Milan 76
Ann Arbor 74
Buffalo 73
Wilmington 49
Cambridge 42
Santa Cruz 38
Beijing 28
Shanghai 18
Chicago 15
Phoenix 12
Southend 12
Bengaluru 11
Dublin 11
Las Vegas 11
Muizenberg 11
Redmond 11
Los Angeles 10
Mountain View 9
Toronto 9
University Park 8
Wuhan 8
San Diego 7
Hangzhou 6
Mississauga 6
Nanjing 6
Ottawa 6
Boardman 5
Boulder 5
Clearwater 5
London 5
Provo 5
Seoul 5
Bangkok 4
Dearborn 4
Guangzhou 4
Hamilton 4
Henderson 4
New York 4
Norwalk 4
Portland 4
Riva 4
Athens 3
Austin 3
Central District 3
Chennai 3
Easton 3
Helsinki 3
Herndon 3
Madison 3
Munich 3
Scottsdale 3
Taipei 3
Alqueidão Da Serra 2
Baden 2
Berlin 2
Bitola 2
Bologna 2
Bucheon 2
Bussolengo 2
Changchun 2
Costa Mesa 2
Council Bluffs 2
Cranford 2
Dallas 2
Darmstadt 2
Des Moines 2
Dossenheim 2
Duncan 2
Hyderabad 2
Khon Kaen 2
Moscow 2
Paris 2
Passau 2
Recife 2
San Francisco 2
San Jose 2
San Pablo 2
Tokyo 2
Uppsala 2
Wesseling 2
Worcester 2
Zhengzhou 2
Amsterdam 1
Ankara 1
Atlanta 1
Aurora 1
Basking Ridge 1
Bellevue 1
Bialystok 1
Birmingham 1
Brandon 1
Brantford 1
Bremerhaven 1
Bucharest 1
Burlington 1
Totale 1.328
Nome #
Fatal Infusion Reaction to Cetuximab : The Need for Predictive Risk Factors and Safer Patient Selection, file dfa8b996-4ea8-748b-e053-3a05fe0a3a96 297
Hepatocellular Carcinoma : A Global Disease in Need of Individualized Treatment Strategies, file dfa8b999-6efc-748b-e053-3a05fe0a3a96 180
Epidermal growth factor receptor gene copy number in esophageal cancer and outcome prediction to gefitinib : does intratumoral heterogeneity matter?, file dfa8b999-8fc0-748b-e053-3a05fe0a3a96 170
Outcome prediction to erlotinib in gastroesophageal adenocarcinomas : can we improve epidermal growth factor receptor and phospho-AKT testing?, file dfa8b999-6cea-748b-e053-3a05fe0a3a96 162
Can stereotactic body radiation therapy be a viable and efficient therapeutic option for unresectable locally advanced pancreatic adenocarcinoma? Results of a phase 2 study, file dfa8b997-ff37-748b-e053-3a05fe0a3a96 155
KRAS mutation in lung metastases from colorectal cancer : Prognostic implications, file dfa8b995-e702-748b-e053-3a05fe0a3a96 138
Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer : a safe and effective approach, file dfa8b995-dc1a-748b-e053-3a05fe0a3a96 132
ARQ 087, an oral pan- fibroblast growth factor receptor (FGFR) inhibitor, in patients (pts) with advanced and/or metastatic intrahepatic cholangiocarcinoma (iCCA), file dfa8b999-7137-748b-e053-3a05fe0a3a96 131
Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib, file dfa8b998-58ad-748b-e053-3a05fe0a3a96 126
Achievements in systhemic therapies in the pre-genomic era in metastatic breast cancer, file dfa8b999-aed8-748b-e053-3a05fe0a3a96 120
Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma, file dfa8b998-ef50-748b-e053-3a05fe0a3a96 119
Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma, file dfa8b998-4b58-748b-e053-3a05fe0a3a96 116
Can stereotactic body radiation therapy be a viable and efficient therapeutic option for unresectable locally advanced pancreatic adenocarcinoma? Results of a phase 2 study, file dfa8b99c-538b-748b-e053-3a05fe0a3a96 10
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma., file dfa8b99c-93f8-748b-e053-3a05fe0a3a96 9
A phase II randomized dose escalation trial of sorafenib in patients with advanced hepatocellular carcinoma, file dfa8b990-bf4e-748b-e053-3a05fe0a3a96 8
A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer : the VanGogh study, file dfa8b995-bf2e-748b-e053-3a05fe0a3a96 5
FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression : a Phase II Study, file dfa8b995-db8e-748b-e053-3a05fe0a3a96 5
Diagnostic accuracy of 11C-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma, file dfa8b996-0a60-748b-e053-3a05fe0a3a96 5
Standardisation of EGFR FISH in colorectal cancer: Results of an international interlaboratory reproducibility ring study, file dfa8b993-e32b-748b-e053-3a05fe0a3a96 4
Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery : a retrospective study, file dfa8b998-ca71-748b-e053-3a05fe0a3a96 4
Molecular determinants of outcome in sorafenib-treated patients with hepatocellular carcinoma, file dfa8b990-d7d9-748b-e053-3a05fe0a3a96 3
Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy, file dfa8b997-f0d5-748b-e053-3a05fe0a3a96 2
Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy: heterogeneity-related issues and prognostic implications, file dfa8b998-40b0-748b-e053-3a05fe0a3a96 2
ARQ 087, an oral pan- fibroblast growth factor receptor (FGFR) inhibitor, in patients (pts) with advanced and/or metastatic intrahepatic cholangiocarcinoma (iCCA), file dfa8b999-7468-748b-e053-3a05fe0a3a96 2
Correlation between the response to cetuximab alone or in combination with irinotecan and the activated/phosphorylated epidermal growth factor receptor in metastatic colorectal cancer, file dfa8b999-b265-748b-e053-3a05fe0a3a96 2
KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab, file dfa8b999-7c80-748b-e053-3a05fe0a3a96 1
Sorafenib in Hepatitis C Virus-Negative Patients With Hepatocellular Carcinoma: Don't Throw the Baby Out With the Bathwater!, file dfa8b999-9924-748b-e053-3a05fe0a3a96 1
Clinical Usefulness of EGFR Gene Copy Number as a Predictive Marker in Colorectal Cancer Patients Treated with Cetuximab : A Fluorescent In situ Hybridization Study, file dfa8b999-9989-748b-e053-3a05fe0a3a96 1
Tivantinib for second-line treatment of advanced hepatocellular carcinoma : a randomised, placebo-controlled phase 2 study, file dfa8b999-9d7f-748b-e053-3a05fe0a3a96 1
Interleukin-2 enhances the natural killer cell response to Herceptin-coated Her2/neu-positive breast cancer cells, file dfa8b999-cb16-748b-e053-3a05fe0a3a96 1
Reply to Y. Pointreau et al, file dfa8b999-d6a0-748b-e053-3a05fe0a3a96 1
Evaluation of HER-2/neu amplification and other biological markers as predictors of response to neoadjuvant anthracycline-based chemotherapy in primary breast cancer: the role of anthracycline dose intensity, file dfa8b99a-28ba-748b-e053-3a05fe0a3a96 1
Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study., file dfa8b99b-d4fe-748b-e053-3a05fe0a3a96 1
Totale 1.915
Categoria #
all - tutte 3.826
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.826


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019113 0 0 0 0 0 0 0 0 0 21 53 39
2019/2020464 27 17 19 82 44 46 44 52 58 27 20 28
2020/2021332 18 27 41 27 23 33 17 40 26 29 25 26
2021/2022444 48 17 23 95 73 12 17 25 20 8 78 28
2022/2023229 3 28 61 40 17 26 10 4 5 20 14 1
2023/202498 4 4 21 6 16 11 13 6 4 13 0 0
Totale 1.915